Navigation Links
Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study
Date:7/16/2014

ly meaningful impact that treatment with NUEDEXTA may have."

PRISM II assessed the safety and efficacy of NUEDEXTA in treating PBA in patients with Alzheimer's disease/dementia, stroke and TBI. While the Alzheimer's disease/dementia cohort is now fully enrolled at 134 patients, at the time of interim analysis 96 patients had evaluable safety data and 68 had effectiveness data (at least 30 treatment days). The study endpoints included a PBA symptom rating (Center for Neurologic Study-Lability Scale; CNS-LS; 7=no symptoms – 35=maximum symptoms), number of weekly PBA episodes, Mini-Mental State Examination (MMSE), quality of life (QOL; 0=no impairment-10=maximum impairment) improvements, and Clinician and Patient Global Impression of Change (CGI-C; PGI-C).

  • At baseline patients had a mean CNS-LS score of 20.2 and were suffering from a median of 29 PBA episodes per week.
  • At the end of the study period, mean CNS-LS improved to 12.8 (P<0.001 compared with baseline) and the median number of PBA episodes decreased to 5 per week.
  • At the end of the treatment period, consistent improvement was observed in other effectiveness measures
    • Mean QOL scores improved from 6.1 at baseline to 2.8 at endpoint (P<0.001)
    • 77.8% of patients or caregivers rated themselves/the patient as being much/very improved on the PGI-C
    • 79.3% of clinicians rated the patient to be much/very much improved on the CGI-C
  • MMSE mean score improved by 0.4 points at end of study from a baseline of 19.0
  • Adverse Events (AE) were reported by a total of 35 (36.5%) patients (6.3% treatment-related), most commonly headache (9.4%), urinary tract infection (5.2%), and diarrhea (4.2%). Eleven patients had serious AEs (only one deemed treatment-related).  Thirteen patients discontinued for AEs. This AE profile was genera
    '/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
2. Avanir Pharmaceuticals to Present at J.P. Morgan 32nd Annual Healthcare Conference
3. Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health
4. Avanir Pharmaceuticals Reports Fiscal 2013 Fourth Quarter Financial and Year-End Business Results
5. Avanir Pharmaceuticals Announces Results for Phase II PRIME Study
6. Preliminary Financial Results, Quarterly Reports and Upcoming Conference Schedules - Research Report on Avanir, BioScrip, Chemed, Foundation Medicine, and Antares
7. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2013 Year End Financial Information
8. Avanir Pharmaceuticals to Host Investor Day on October 29, 2013
9. Avanir Pharmaceuticals Announces Enrollment of First Patient in Study of AVP-923 for the Treatment of Levodopa Induced Dyskinesia in Parkinsons Disease
10. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
11. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , July 29, 2015  ViaCyte, Inc., a privately-held regenerative ... the treatment of diabetes in clinical trials, today announced the opening ... ONE, or S afety, T olerability, and E ... Diabetes.  The new site, which is the first in ... Hospitals in Edmonton , Alberta.  ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today ... a national broadcast news segment in Australia ... following regulatory and reimbursement approval in that country. ... 1.2 million Australians living with diabetes. As a case in ... great solution for a 13 year old boy with Type ...
(Date:7/29/2015)...  Fifty groups representing 500,000 patients, doctors, and researchers ... the AllTrials campaign in the US. The global campaign ... to be registered and the results from it reported. ... explains: "Patients want the treatments that are best ... works. Unfortunately, we now know that around half of ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3
... FRANKLIN PARK, Ill., Jan. 5, 2011 ... converter of plastics in the lamination, print, packaging, ... Interfilm Holdings, Inc., one of the largest and ... in the United States. This acquisition supports Transilwrap,s ...
... ERES  - News ), a global ... and medical device industries, announced that its eC-SSRS (Electronic ... the newly introduced Food and Drug Administration (FDA) guidance ... Trials."   A copy of this guidance can ...
Cached Medicine Technology:Transilwrap Company Acquires Interfilm Holdings 2eC-SSRS Solution from ERT Facilitates Compliance with New FDA Guidance on Suicidality Assessment in Clinical Trials 2eC-SSRS Solution from ERT Facilitates Compliance with New FDA Guidance on Suicidality Assessment in Clinical Trials 3
(Date:7/29/2015)... ... July 29, 2015 , ... The ... development for Atherosclerosis. Atherosclerosis is a slow, progressive disease that may start in ... produce first-in-class and best-in-class products. Complete report on Atherosclerosis Pipeline with 78 market ...
(Date:7/29/2015)... ... 2015 , ... Ticket Down is a reliable source of authentic tickets for ... , The international soccer schedule of matches played on American soil continues to ... one of the world’s greatest teams, Brazil, will travel to North America to compete ...
(Date:7/29/2015)... Rhinebeck, NY (PRWEB) , ... July 29, 2015 ... ... 555 Fitness as a sponsor, with its Topricin® Pain Relief and Healing Cream ... is a firefighter-founded web-based organization that is actively addressing Line of Duty Deaths ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... According to ... flies revealed a gene which is directly responsible for stimulating and perpetuating alcohol use ... in the journal entitled Proceedings of the National academy of Sciences, and has given ...
(Date:7/29/2015)... ... 29, 2015 , ... On July 26th the Miami ... for nicotine laced liquid products. Their report says cigarette use has decreased recently ... particularly troublesome to addiction professionals as many of the candy flavors available are ...
Breaking Medicine News(10 mins):Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3
... Whistleblower lawsuit ... must pay $19.4 million plus interest to the United States government after it allegedly set ... ... States District Court Judge William J. Haynes, Jr. issued an order on March 22, 2010 ...
... ... healthcare industry goals for standardized product identification. Report summarizes experiences of hospitals, manufacturers, ... ... new industry report summarizing the experiences of 14 healthcare early adopters in synchronizing ...
... pigs, scientists say , WEDNESDAY, March 24 (HealthDay News) ... stick onto organs promises better diagnosis and control of ... report. , For example, "in the heart, we could ... arrhythmia much faster than is now done," explained study ...
... University in Silicon Valley will host a one-day workshop ... focus on the role of high-tech communication and other ... plan to identify mutually beneficial research agendas and exchange ... campus," said Martin Griss, director of Carnegie Mellon,s Silicon ...
... are few after time, but death risk is then ... News) -- Breast cancer recurrence in the same area ... of subsequent cancer spread and death in patients who,ve ... has found. , Researchers analyzed data from 7,749 European ...
... White Horse will ... with social media. , ... OR (PRWEB) March 24, 2010 -- To help BtoB companies engage prospects with social media, ... Media , a complimentary Webinar event offering a proven approach for lead cultivation with social ...
Cached Medicine News:Health News:Fresenius Medical Holdings, Inc. Ordered To Pay $19.4 Million For Fraudulent Medicare Claims 2Health News:Fresenius Medical Holdings, Inc. Ordered To Pay $19.4 Million For Fraudulent Medicare Claims 3Health News:Healthcare Early-Adopters Issue Industry Report for Using Data Synchronization 2Health News:Healthcare Early-Adopters Issue Industry Report for Using Data Synchronization 3Health News:Healthcare Early-Adopters Issue Industry Report for Using Data Synchronization 4Health News:Healthcare Early-Adopters Issue Industry Report for Using Data Synchronization 5Health News:New Sensors Stick to Organs to Monitor Health 2Health News:Breast Cancer's Return in Original Tumor Site a Bad Sign 2Health News:Webinar Shares Proven Social Media Approach to BtoB Lead Generation 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: